Latest Richard A. Lerner Stories
A team led by scientists at The Scripps Research Institute (TSRI) has discovered an unusual bacterial protein that attaches to virtually any antibody and prevents it from binding to its target.
LA JOLLA, Calif., Feb.
Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug BenlystaÂ® (belimumab), approved today by the U.S. Food and Drug Administration. BenlystaÂ®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.
LA JOLLA, Calif., Feb. 25, 2011 /PRNewswire/ -- Renowned biochemist Michael A. Marletta, PhD, has been named by the Board of Trustees today as the next president of The Scripps Research Institute, effective January 1, 2012. He will succeed President Richard A.
- The governor of a province or people.